Chiesi Deutschland

About Chiesi Deutschland

Chiesi, an international, research-driven biopharmaceutical group, develops and markets innovative medicinal and non-medicinal solutions in three business areas: - AIR: Products and services related to respiratory diseases, as well as for self-medication, including pharmacy-only medicines and cosmetics; - RARE: Treatment of patients with rare and very rare diseases; - CARE: Medicines for transplant recipients. The company’s purpose is to improve people's quality of life, while acting responsibly towards society and the environment. Chiesi has been certified as a B Corp since 2019. This certification ensures that Chiesi's sustainable management is measured, assessed and continuously improved according to independent global standards (learn more at bcorp.com). The company aims to achieve net zero emissions by 2035 (Scope 1-3). These efforts are communicated transparently via the website https://actionoverwords.org/de/ and in our sustainability report (https://www.chiesi.com/en/sustainability/sustainability-report). The Chiesi Group employs more than 7,000 people in 31 countries worldwide, Chiesi GmbH, based in Hamburg, employs around 400 people across Germany. Chiesi is recognised as a Top Employer by the Top Employers Institute time (https://www.top-employers.com/de/employer/chiesi-gmbh-2/), and a “Great Place to Work” (https://greatplacetowork.de/beste-arbeitgeber/chiesi-gmbh-and-amryt-gmbh). Career: www.chiesi.de/en/career Data protection: www.chiesi.de/en/data-privacy--cookies Imprint: Chiesi GmbH Ludwig-Erhard-Str. 34 20459 Hamburg Tel.: +49 (0)40 897 24-0 Fax: +49 (0)40 897 24-212 info.de(at)chiesi.com Managing Director: Leonardo Mallmann Commercial register entry: Hamburg County Court HRB 84675 Tax ID No. DE222426963 Competent regulatory authority: Freie und Hansestadt Hamburg Behörde für Justiz und Verbraucherschutz Amt für Verbraucherschutz Abteilung Pharmaziewesen und Medizinprodukte Billstraße 80 20539 Hamburg